NXM

5.77%

4.9¢ nexus minerals limited

There is no spp or similar being offered.Probably a good thing...

First 44 Last

Share
Profile

Follow
perdant

4,614 Posts.

722

11/11/21

15:27

Post #: 57499602
Share
Originally posted by Stocktaking: ↑

CR has been detailed in the AFR this morning, it's $19m at 46c (with 41.3 million shares expected). I'm very positive on this:

Fully expect that there was a large 'exploration & evaluation' expense paid shortly after 30 September for the previous quarter's drilling. In my opinion, $7.2m in the bank would have reduced shortly after 30 Sept;

30,000m drill program is going to cost ~$4.5m and the company wants to keep rigs spinning into the new year = further costs. Management and staff can see the company's momentum and want to continue pumping out drilling results (there will be no pause like in Jan - Apr 2021) - it would be much more detrimental to pause drilling for a month due to a lack of cash;

I had a chat with a few brokers over the last few weeks and Hartleys at the AGM. They are beating down the door and the company has received unsolicited calls with offers to throw money at them (I've heard a broker comment that Templar is 'Karari on steroids' - no idea if this broker has the geological training to back this up). Management continues prudent approach and isn't significantly diluting the register;

Company's market cap is now at a stage where some of the larger funds / investors etc. have had their risk factors ticked off and can get in;

Exploration team is very confident on the coming results and their understanding of the geology - they just need to get the drills in the ground. Andy has been saying this in presentations for years, the deposits are constrained only by the extent of Nexus drilling to date. This CR allows us to ramp up hard and find out just how big this is;

Company has typically seen multiples of growth following CR. 4.5 cent raise in June 2020 led to a 15c raise in November 2020 and we're now raising at 46 cents - I expect similar results from this raise. Raising now also means that the discount is small - if we were desperate for cash, there would have been potential to push the price down;

Any short term gain received if NXM hadn't raised now will (in my opinion) be dwarfed by the next 12 months;

Historically ~75% of NXM's cash is pumped into exploration and it has lead to low cost ounces;

Possibility of a major cornerstone investor coming on board to take this forward;

Whilst the gold price appears to be breaking out, needs confirmation on the weekly. We are still early in this gold bull market and it still has a few years to run. I expect massive returns for those who are patient but heaps of bumps along the way.

NXM looks poised to benefit from these tailwinds.

Expand

There is no spp or similar being offered.

Probably a good thing as we can just raise and move on and not wait for retail to drag their feet for two weeks.
AT is presenting at the RIU conference in WA on December 2nd.
Hopefully you can watch online.
Presso is 3:45 WAST
NXM Price at posting: 50.0¢ Sentiment: Hold Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 24 more messages in this thread...

First 44 Last

Add NXM (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change -0.003(5.77%)		Mkt cap ! $23.82M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.9¢	$15.06K	307.3K

Buyers (Bids)

No.	Vol.	Price($)
1	100000	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	134086	3

View Market Depth

No.	Vol.	Price($)
1	100000	0.050
2	44018	0.049
1	103250	0.048
1	272500	0.043
2	390000	0.042

Price($)	Vol.	No.
0.052	134086	3
0.053	170000	1
0.054	110527	2
0.055	100000	1
0.056	75000	1

Last trade - 13.35pm 04/10/2024 (20 minute delay)

NXM (ASX) Chart

There is no spp or similar being offered.Probably a good thing...

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

There is no spp or similar being offered.Probably a good thing...

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News